Thomas Jefferson University: Kimmel Cancer Center
Welcome,         Profile    Billing    Logout  
 4 Trials 
3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hoffman-Censits, Jean
NCT05312671: Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Recruiting
2
63
US
Atezolizumab, Tecentriq, Carboplatin, CBDCA, Paraplatin, JM-8, NSC-241240, Cisplatin, Cis-Diaminedichloroplatinum, CDDP, Etoposide, VP-16, VePesid, VP-16-213, EPEG, epipodophyllotoxin, NSC # 141540, Cystectomy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Genentech, Inc.
Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder
06/25
06/27
NCT05656235: Renal Retention in High Grade Upper Tract Urothelial Cancer

Recruiting
2
20
US
Enfortumab vedotin, Padcev, Pembrolizumab, Keytruda
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Astellas Pharma Inc, Seagen Inc., Merck Sharp & Dohme LLC
High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder
06/28
06/29
NCT04200963: A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

Completed
1
78
US
IK-175, KYN-175, IK-175 and nivolumab, KYN-175 and nivolumab
Ikena Oncology, Bristol-Myers Squibb
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer, Bladder Disease, Solid Tumor, Solid Carcinoma, Solid Tumor, Adult, Metastatic Cancer, Advanced Solid Tumor, Advanced Cancer, Metastatic Bladder Cancer, Metastatic Urothelial Carcinoma, Locally Advanced Solid Tumor, Neoplasms, Neoplasm Metastasis, Neoplasm Malignant, Neoplasm, Bladder, Urothelial Neoplasm, Neoplasm, Urinary Bladder, Bladder Neoplasm, Bladder Urothelial Carcinoma
07/23
07/23

Download Options